Amneal Pharmaceuticals AMRX Insider Ownership

Updated Oct 10, 2026

Over the trailing 12 months, AMRX insiders sold $9.82 million worth of shares (629.69K shares) in open-market trades, with no open-market purchases.

• By number of insiders, Amneal Pharmaceuticals saw 5 insiders sell on the open market over the past 12 months and none buy.
• The largest open-market sales of AMRX in the past 12 months were by Nikita Shah (Executive Vice President), totaling $4.14 million (278.26K shares), most recently on August 12, 2026.
• The latest open-market trade on record is a sale of 50K shares for $882,000 by John Kiely (Director) on August 13, 2026.
• Apart from open-market trades, AMRX insiders received 19.43Mn shares in stock awards, acquired 3.18Mn shares through option exercises and conversions, gave up 1.74Mn shares to cover taxes or exercise prices and gave away 262.87K shares as gifts in the past 12 months.
• Business Quant data puts insider holdings in AMRX at 152.29Mn shares across insiders' latest Form 4 filings, up 13.93% from 133.66Mn shares at the end of Q2 2026 and down 3.74% from 158.21Mn shares at the end of Q3 2025.
• Indirect holdings, through trusts, partnerships, family members and other entities, make up 94.90% (144.53Mn shares) of Amneal Pharmaceuticals' insider total, with the other 5.10% (7.76Mn shares) held directly.
• The insider holdings in Amneal Pharmaceuticals belong to 16 insiders who have reported on Form 4 within the past two years.
• Amneal Pharmaceuticals' three biggest insider holders are Tushar Bhikhubhai Patel (10% owner, 61.34Mn shares), Chintu Patel (Co-CEO, 32.52Mn shares) and Gautam Patel (Director, 32.31Mn shares), based on their latest Form 4 filings.
• The largest insider, Tushar Bhikhubhai Patel, holds 40.28% of AMRX's insider total.
• Institutional holders reported 51.07% of Amneal Pharmaceuticals' outstanding shares for Q2 2026; insiders' latest Form 4 filings put their stake at about 47.71%, and other investors, including the public, hold the remaining 1.22%.
• In the last 12 months, 37 Form 4 filings with transactions in AMRX stock came from 15 insiders.
• Insider figures for AMRX include Form 4 filings through September 21, 2026.